日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Exploring survival-associated transcriptomic subtypes in ovarian cancer using RNAseq from FFPE tissues in a clinical trial cohort

利用临床试验队列中FFPE组织的RNA测序技术探索卵巢癌中与生存相关的转录组亚型

期刊:Translational Oncology
影响因子:4.1
doi:10.1016/j.tranon.2026.102740
Kjeldsen, Maj K; Bagger, Frederik Otzen; Roed, Henrik; Nyvang, Gitte-Bettina; Haslund, Charlotte Aaquist; Knudsen, Anja Oer; Motavaf, Anne Krejbjerg; Malander, Susanne; Anttila, Maarit; Lindahl, Gabriel; Mäenpää, Johanna; Dimoula, Maria; Werner, Theresa; Iversen, Trine Zeeberg; Hietanen, Sakari; Fokdal, Lars; Dahlstrand, Hanna; Bjørge, Line; Birrer, Michael; Mirza, Mansoor Raza; Rossing, Maria
Sequencing
肿瘤
肿瘤免疫
卵巢癌
发表日期：2026
文献求助 收藏

Beyond HRD Status: Unraveling Genetic Variants Impacting PARP Inhibitor Sensitivity in Advanced Ovarian Cancer

超越HRD状态：揭示影响晚期卵巢癌PARP抑制剂敏感性的遗传变异

期刊:Cancer Research Communications
影响因子:3.3
doi:10.1158/2767-9764.CRC-24-0294
Kjeldsen, Maj K; Jørgensen, Morten; Grønseth, Dina Sofie B; Schønemann-Lund, Martin; Nyvang, Gitte-Bettina; Haslund, Charlotte Aaquist; Knudsen, Anja Oer; Motavaf, Anne Krejbjerg; Malander, Susanne; Anttila, Maarit; Lindahl, Gabriel; Mäenpää, Johanna; Dimoula, Maria; Werner, Theresa L; Iversen, Trine Zeeberg; Hietanen, Sakari; Fokdal, Lars; Dahlstrand, Hanna; Bjørge, Line; Birrer, Michael J; Mirza, Mansoor R; Rossing, Maria
PARP
肿瘤
肿瘤免疫
卵巢癌
发表日期：2024
文献求助 收藏

Safe to save blood in ovarian cancer surgery - time to change transfusion habits

卵巢癌手术中保留血液是安全的——是时候改变输血习惯了

期刊:Acta Oncologica
影响因子:2.2
doi:10.2340/1651-226X.2024.40435
Norbeck, Anna; Bengtsson, Jesper; Malander, Susanne; Asp, Mihaela; Kannisto, Päivi
肿瘤
肿瘤免疫
卵巢癌
发表日期：2024
文献求助 收藏

Tru-Cut Biopsy in Gynecological Cancer: Adequacy, Accuracy, Safety and Clinical Applicability

妇科肿瘤的Tru-Cut活检：充分性、准确性、安全性和临床适用性

期刊:Journal of Multidisciplinary Healthcare
影响因子:2.4
doi:10.2147/JMDH.S396788
Asp, Mihaela; Mockute, Ingrida; Måsbäck, Anna; Liuba, Karina; Kannisto, Päivi; Malander, Susanne
肿瘤
肿瘤免疫
发表日期：2023
文献求助 收藏

Age and Referral Route Impact the Access to Diagnosis for Women with Advanced Ovarian Cancer

年龄和转诊途径会影响晚期卵巢癌女性获得诊断的机会

期刊:Journal of Multidisciplinary Healthcare
影响因子:2.4
doi:10.2147/JMDH.S401601
Norbeck, Anna; Asp, Mihaela; Carlsson, Tobias; Kannisto, Päivi; Malander, Susanne
肿瘤
肿瘤免疫
卵巢癌
发表日期：2023
文献求助 收藏

The role of computed tomography in the assessment of tumour extent and the risk of residual disease after upfront surgery in advanced ovarian cancer (AOC)

计算机断层扫描在评估晚期卵巢癌（AOC）一线手术后肿瘤范围和残留病灶风险中的作用

期刊:Archives of Gynecology and Obstetrics
影响因子:2.5
doi:10.1007/s00404-022-06466-8
Asp, Mihaela; Malander, Susanne; Wallengren, Nils-Olof; Pudaric, Sonja; Bengtsson, Johan; Sartor, Hanna; Kannisto, Päivi
肿瘤
肿瘤免疫
卵巢癌
发表日期：2022
文献求助 收藏

Incidence and survival of epithelial ovarian, fallopian tube, peritoneal, and undesignated abdominal/pelvic cancers in Sweden 1960-2014: A population-based cohort study

1960-2014年瑞典上皮性卵巢癌、输卵管癌、腹膜癌和未明确分类的腹部/盆腔癌的发病率和生存率：一项基于人群的队列研究

期刊:BMC Cancer
影响因子:3.4
doi:10.1186/s12885-021-08169-w
Leandersson, Pia; Hogberg, Thomas; Dickman, Paul W; Malander, Susanne; Borgfeldt, Christer
肿瘤
肿瘤免疫
卵巢癌
发表日期：2021
文献求助 收藏

MET Expression and Cancer Stem Cell Networks Impact Outcome in High-Grade Serous Ovarian Cancer

MET 表达和癌症干细胞网络影响高级别浆液性卵巢癌的结果

期刊:Genes
影响因子:
doi:10.3390/genes12050742
Maria Bååth, Jenny-Maria Jönsson, Sofia Westbom Fremer, Laura Martín de la Fuente, Lena Tran, Susanne Malander, Päivi Kannisto, Anna Måsbäck, Gabriella Honeth, Ingrid Hedenfalk
发育与干细胞
肿瘤
卵巢癌
干细胞
WB
发表日期：2021
文献求助 收藏

PD-1/PD-L1 expression and tumor-infiltrating lymphocytes are prognostically favorable in advanced high-grade serous ovarian carcinoma

PD-1/PD-L1 表达和肿瘤浸润淋巴细胞对晚期高级别浆液性卵巢癌具有预后良好作用

期刊:Virchows Archiv
影响因子:3.4
doi:10.1007/s00428-020-02751-6
Laura Martin de la Fuente, Sofia Westbom-Fremer, Nicolai Skovbjerg Arildsen, Linda Hartman, Susanne Malander, Päivi Kannisto, Anna Måsbäck, Ingrid Hedenfalk
肿瘤
卵巢癌
其它细胞
发表日期：2020
文献求助 收藏

A multiplex biomarker assay improves the diagnostic performance of HE4 and CA125 in ovarian tumor patients

多重生物标志物检测可提高HE4和CA125在卵巢肿瘤患者中的诊断性能

期刊:PLoS One
影响因子:2.6
doi:10.1371/journal.pone.0240418
Leandersson, Pia; Åkesson, Anna; Hedenfalk, Ingrid; Malander, Susanne; Borgfeldt, Christer
肿瘤
肿瘤免疫
发表日期：2020
文献求助 收藏